🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-AB...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-04-16
Trial ID
NCT06828588
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of ribociclib...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2022-04-07
Trial ID
NCT05319873
This is a single-center, phase 1b study evaluating the safety and feasibili...
Status
Recruiting
Location
Netherlands Cancer Institute
Start Date
2023-12-18
Trial ID
NCT06162559
Treatments Being Tested
Cancer drugs which target the effects of abnormal gene changes are called '...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2018-03-23
Trial ID
NCT03297606
The overall survival of patients with metastatic breast cancer has steadily...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest - Site Paul Papin
Start Date
2021-12-17
Trial ID
NCT05041842
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-28
Trial ID
NCT04538742
Treatments Being Tested
This is a prospective, randomized, 2-arm, Phrase 2, superiority and multice...
Status
Unknown
Location
Peking University International Hospital
Start Date
2021-10-01
Trial ID
NCT04760431
Treatments Being Tested
The purpose of this study is to test the safety and effectiveness of a sequ...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-08-08
Trial ID
NCT06439693
This study is being done to see if tucatinib works better than placebo when...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Start Date
2022-03-07
Trial ID
NCT05132582
Treatments Being Tested